SPYRE THERAPEUTICS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $2.6M | $38.7M | $29.3M |
| FY2016 | $4.1M | $67.1M | $47.7M |
| FY2017 | $5.7M | $56.1M | $12.8M |
| FY2018 | $10.3M | $77.7M | $22.5M |
| FY2019 | $23.1M | $83.2M | $19.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $2.6M | $38.7M | $29.3M |
| FY2016 | $4.1M | $67.1M | $47.7M |
| FY2017 | $5.7M | $56.1M | $12.8M |
| FY2018 | $10.3M | $77.7M | $22.5M |
| FY2019 | $23.1M | $83.2M | $19.3M |